O’Melveny advised Superfluid DX on the transaction.Superfluid DX, a San Francisco-based company which specializes in advancing solutions for the diagnosis of Alzheimer’s disease, closed its oversubscribed…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
